Le Lézard
Classified in: Health
Subject: PER

Central Logic announces additions to the executive team: Maija Costello, Samantha Endres, and Robert Zdon


SANDY, Utah and MINNEAPOLIS, Sept. 24, 2020 /PRNewswire-PRWeb/ -- Central Logic, the healthcare industry's innovator in patient orchestration and tools to accelerate access to care, announces the appointments of three individuals to the company's executive team: Maija Costello, Vice President of People & Culture; Samantha Endres, CPA, Chief Financial Officer; and Robert Zdon, Chief Marketing Officer.

"The deep healthcare and leadership experience of all three new executive team members will support our core mission of empowering our clients to deliver the right patient care at the right location without delay," stated Central Logic CEO Angie Franks. "It's especially important during this difficult time in healthcare to make sure we're onboarding professionals of the highest caliber who understand the extreme challenges of health systems, hospitals, and public health agencies. I feel confident that Maija, Sam, and Bob embody all of these qualities."

Maija Costello
As Vice President of People & Culture, Costello will drive the execution of Central Logic's talent acquisition, compensation and benefits, and culture initiatives.

"People are our greatest asset and a key differentiator for Central Logic; they enable us to continue the development and delivery of compelling solutions to our clients," said Franks. "Maija will play a pivotal role in our ability to attract and retain the very best talent."

Costello possesses several years of experience in healthcare and human resources. Prior to joining Central Logic, she was a Management Consultant Manager at Accenture, where her responsibilities included leading enterprise readiness & integration and human resources initiatives for Comprehensive Cancer Center. Other previous healthcare-related positions include People Operations Manager at Bloom Health in the Minneapolis-St. Paul area. Among Costello's educational credentials is an MBA degree from the University of Minnesota-Carlson School of Management.

Samantha Endres
As Chief Financial Officer, Endres will oversee management of the company's finances, including financial planning, risk management, financial reporting, and data analysis.

"Sam is a very accomplished financial executive with more than 20 years of progressive leadership experience," said Franks. "Her proven track record of process management, financial operations improvement, and business development will be a tremendous asset to Central Logic."

Endre's healthcare experience includes serving as Vice President of Financial Planning and Analysis for Healthland, a provider of EHR software to small and rural hospitals nationwide. Most recently, she was Chief Financial Officer of West Academic Publishing. Other previous positions include Senior Director, Finance, at Thomson Reuters. Andres earned a bachelor's degree in accounting from Augsburg University and an MBA degree in finance from Metropolitan State University.

Robert Zdon
As Chief Marketing Officer, Zdon will be responsible for overseeing the planning, development, and execution of Central Logic's marketing and visibility initiatives.

"Bob is a seasoned, disciplined marketing strategist and leader with an extensive background in healthcare," said Franks. "He understands our market, and I'm confident that he and his team will contribute to our revenue growth through effective marketing, advertising, and public relations."

Most recently, Zdon was President of RAZR Marketing and Grayduck Health, a Minneapolis-based marketing and technology agency. Before that, he held senior leadership roles at other healthcare- and technology-focused companies, including Healthland, Universal Hospital Services, Hill-Rom, and Allina Health. Zdon earned bachelor's degrees in electrical engineering and biomedical engineering from the University of Minnesota-Twin Cities.

About Central Logic

For health systems, managing patient transfers is a life-saving endeavor. Central Logic is a pioneer in the space and was founded solely to support this mission. Our flexible, purpose-built solution provides superior real-time visibility and unmatched business intelligence to optimize the operations of health system Access Centers. Clients count on Central Logic to deliver strong growth, find new ways to improve patient outcomes and make their operations more effective, today and into the future. Based in Utah and Minnesota, Central Logic is an industry leader with a 93% customer retention rate. The company has been named a "fastest growing private company" by both Inc. 500 and Utah Business Magazine. For more information, visit https://centrallogic.com and follow the company on LinkedIn.

 

SOURCE Central Logic


These press releases may also interest you

at 22:33
Corventive Health, a provider of cloud-based and AI technology solutions, announced a partnership with Halfpenny Technologies, an Accumen, Inc. company today. This partnership fortifies Corventive's core capability of delivering clinical insights...

at 22:03
Alterity Therapeutics ("Alterity" or "the Company") today announced it has commenced enrolling patients with Multiple System Atrophy (MSA) in its bioMUSE Study in the United States....

at 20:39
Trusted health and lifestyle expert, Dr. Yael Varnado gives advice for fall health and wellness. Dr. V is a practicing physician. STAYING WELL Taking better care of ourselves can be as easy as swapping out a light bulb. Choosing the right lighting...

at 20:10
Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Evaluation (CDE) of...

at 20:00
Drawbridge Health, a healthcare technology company redefining the blood draw experience for both patients and healthcare providers, today announced a further investment from Sumitomo Dainippon Pharma Co., Ltd. ("Sumitomo Dainippon Pharma") as well as...

at 19:35
EdiGene, Inc. ( "Company", or "EdiGene"), today announced the Center for Drug Evaluation (CDE) of China National Medical Products Administration (NMPA) has accepted for review the Company's Investigational New Drug (IND) application for ET-01,...



News published on 24 september 2020 at 15:00 and distributed by: